A groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours. The drug works by disarming a key...

A groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours. The drug works by disarming a key...

Merck's ifinatamab deruxtecan wins FDA Breakthrough Therapy status for treating adults with extensive-stage small cell lung cancer.

Merck's ifinatamab deruxtecan wins FDA Breakthrough Therapy status for treating adults with extensive-stage small cell lung cancer.

Redmond, WA and Princeton, NJ – August 18, 2025 – SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers...

A new study has shown that radiation therapy can make certain lung cancers more responsive to immunotherapy, even if they usually don’t respond to...

A new study may offer a breakthrough for patients with advanced melanoma who don’t respond to current immunotherapy treatments. The research,...

Chinese scientists have successfully transplanted engineered human brain cells into mice, producing striking effects on mood and behavior. The...

Chinese scientists have successfully transplanted engineered human brain cells into mice, producing striking effects on mood and behavior. The...

About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit from the current standard chemotherapy....